New Studies. In case of new studies launched by the Lead Company in order to fulfil the requirements of REACH annexes 7 and 8 the costs to be shared are equal to the real costs paid plus the relevant Administrative Expenses. A rebate of 50% will then be applied to the cost of the new studies for the restricted use for REACH purposes only (no transfer of the actual study report and study data). If rights to use such new studies are to be granted to third parties to be used for another purpose, a bilateral agreement shall be developed with the Lead Company on behalf of all co-owners of the new studies, with any compensation obtained from a third party to be shared equally between the co-owners. In the event that new studies must be commissioned at the request of the European Chemicals Agency (ECHA) for REACH annexes 9 and 10 the costs will be shared equally between all registrants (ie Consortium and SIEF members). All calculated values must be documented.
Appears in 4 contracts
Samples: Dimethylglutarate Sief Agreement, Sief Agreement, Sief Agreement
